Postmenopause Clinical Trial
Official title:
A Phase II Pilot Study to Evaluate the Safety and Efficacy of J867 Administered With Estrogen to Postmenopausal Women
The objective of this study is to determine the safety and effectiveness of 3 asoprisnil doses when administered to postmenopausal women with Premarin® 0.625 mg.
The objective of this study is to determine the safety and effectiveness of asoprisnil 5, 10, and 25 mg, compared to placebo, when administered to postmenopausal women, with Premarin® 0.625 mg, for 12 weeks. Pharmacodynamic effects to be assessed include bleeding pattern, endometrial biopsy results, and endometrial thickness. Safety assessments will include clinical laboratory results, physical examination with vital signs, pelvic and breast examinations, ultrasound results, and adverse events ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05448079 -
The Effect of Sexual Counseling Given According to the PLISSIT Model on FSFI, MAS and SQOL-F of Postmenopausal Women
|
N/A | |
Completed |
NCT00745173 -
Study Evaluating Premarin and Bazedoxifene Potential Interaction
|
Phase 1 | |
Completed |
NCT00550433 -
Study Evaluating Bazedoxifene/CE in Postmenopausal Women
|
Phase 1 | |
Completed |
NCT00913926 -
Effects of Wellnara on Climacteric Symptoms
|
N/A | |
Completed |
NCT00515593 -
PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)
|
N/A | |
Completed |
NCT00381251 -
Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.
|
Phase 1 | |
Completed |
NCT00185328 -
Efficacy and Tolerability of Angeliq in Thai Women
|
Phase 4 | |
Completed |
NCT00484107 -
Tolerability & Safety of Premarin Vaginal Cream in Indian Postmenopausal Women
|
Phase 4 | |
Completed |
NCT00023543 -
Reduction of Triglycerides in Women on Hormone Replacement Therapy
|
Phase 2 | |
Completed |
NCT00006407 -
Sex Steroid Hormones and Risk of CHD in Women
|
N/A | |
Completed |
NCT00006539 -
Thrombotic, Inflammatory & Gene Markers of CVD in Women
|
N/A | |
Completed |
NCT00010712 -
Effects of Black Cohosh on Menopausal Hot Flashes
|
Phase 2 | |
Completed |
NCT00001752 -
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
|
Phase 2 | |
Completed |
NCT00005515 -
Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
|
N/A | |
Completed |
NCT00000481 -
Women's Health Trial: Feasibility Study in Minority Populations
|
Phase 3 | |
Completed |
NCT00000466 -
Postmenopausal Estrogen/Progestin Interventions (PEPI)
|
Phase 3 | |
Completed |
NCT00543634 -
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
|
Phase 1 | |
Completed |
NCT06115577 -
Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes
|
||
Completed |
NCT01556737 -
Effect of Two Different Isoflavone Supplement Preparations on Gene-expression in Postmenopausal Women
|
N/A | |
Completed |
NCT00455741 -
Postmenopausal Women Estrogen and Progesterone Infusion
|
Phase 1/Phase 2 |